Product Information

WARFARIN SODIUM 3 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1008 per EA under NDC 00093171501. Its NADAC has been published 584 times since Sep 16, 2015.

FDA first approved this application on Jul 5, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

WARFARIN SODIUM 3 MG TABLET

Warfarin Sodium
$0.1008per EA

Strength

3 mg/1

NDC

00093171501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

WARFARIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA040616

FDA Approved

7/5/2006

TE Code

AB

On Market Since

7/14/2015

Pharmacological Classes

Vitamin K Antagonist
Vitamin K Inhibitors

Price Statistics

The NADAC for WARFARIN SODIUM 3 MG TABLET has been published 584 times since Sep 16, 2015, and over the history we have for it it has declined 46.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1008 per EA
All-time high$0.2016 (Jan 13, 2016)
All-time low$0.0779 (Dec 20, 2023)
52-week high$0.1008
52-week low$0.0829
Median price$0.1099
Average price$0.1168
Largest weekly change-32.4% (Dec 20, 2023)
Weeks tracked584
Tracking sinceSep 16, 2015

Price History

1W

+0.0%

1M

+2.1%

3M

+5.7%

6M

+17.6%

1Y

+6.6%

3Y

-2.1%

5Y

+8.2%

All

-46.9%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of WARFARIN SODIUM 3 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for WARFARIN SODIUM 3 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1008 per EA (NDC 00093171501), effective Nov 18, 2026.

How has the price of WARFARIN SODIUM 3 MG TABLET changed over time?

Over the history we have for it, the NADAC for WARFARIN SODIUM 3 MG TABLET has declined 46.9%. It has been tracked across 584 weekly CMS publications since Sep 16, 2015.

What are the highest and lowest recorded NADAC prices for WARFARIN SODIUM 3 MG TABLET?

Since Sep 16, 2015, the NADAC for WARFARIN SODIUM 3 MG TABLET has ranged from a low of $0.0779 (Dec 20, 2023) to a high of $0.2016 (Jan 13, 2016), with a median of $0.1099 per EA.

Are there cheaper alternatives to WARFARIN SODIUM 3 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, JANTOVEN 3 MG TABLET, is $0.0986 per EA — about 2% below WARFARIN SODIUM 3 MG TABLET.

Who manufactures WARFARIN SODIUM 3 MG TABLET?

WARFARIN SODIUM 3 MG TABLET (NDC 00093171501) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.